Interaction of DOPA decarboxylase inhibitors with the effect of alpha-methyldopa on blood pressure and tissue monoamines in rats.
D000818:Animals; D065105:Aromatic Amino Acid Decarboxylase Inhibitors; D001794:Blood Pressure / Q000187:drug effects*; D001923:Brain Chemistry; D002395:Catecholamines / Q000032:analysis*; D004298:Dopamine / Q000032:analysis; D004357:Drug Synergism; D006834:Hydrazines / Q000494:pharmacology; D008297:Male; D008722:Methods; D008750:Methyldopa / Q000494:pharmacology*; D009206:Myocardium / Q000032:analysis; D009638:Norepinephrine / Q000032:analysis; D051381:Rats; D012701:Serotonin / Q000032:analysis; D013997:Time Factors
D065105:Aromatic Amino Acid Decarboxylase Inhibitors; D002395:Catecholamines; D006834:Hydrazines; D012701:Serotonin; D008750:Methyldopa; D004298:Dopamine; D009638:Norepinephrine